Biomarkers of the metabolic syndrome and breast cancer prognosis.
about
Preoperative Metabolic Syndrome Is Predictive of Significant Gastric Cancer Mortality after Gastrectomy: The Fujian Prospective Investigation of Cancer (FIESTA) StudyPreoperative metabolic syndrome and prognosis after radical resection for colorectal cancer: The Fujian prospective investigation of cancer (FIESTA) study.Hypertension predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
P2860
Biomarkers of the metabolic syndrome and breast cancer prognosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biomarkers of the metabolic syndrome and breast cancer prognosis.
@en
Biomarkers of the metabolic syndrome and breast cancer prognosis.
@nl
type
label
Biomarkers of the metabolic syndrome and breast cancer prognosis.
@en
Biomarkers of the metabolic syndrome and breast cancer prognosis.
@nl
prefLabel
Biomarkers of the metabolic syndrome and breast cancer prognosis.
@en
Biomarkers of the metabolic syndrome and breast cancer prognosis.
@nl
P2860
P356
P1433
P1476
Biomarkers of the metabolic syndrome and breast cancer prognosis
@en
P2093
Meng-Hua Tao
Qiu-Li Zhu
P2860
P304
P356
10.3390/CANCERS2020721
P50
P577
2010-04-28T00:00:00Z